Hannah Llorin

Llorin holds a Bachelor of Science in Biology from Stanford University and a Master of Science in Human Genetics and Genetic Counseling also from Stanford. She is currently a research fellow at the University of Minnesota, studying clinical outcomes in pharmacogenomics.

Growing up with identical twin brothers sparked her interest in genetics. At Stanford, she led research on tumor genomic profiling and worked at the Center for Inherited Cardiovascular Disease. Later, she served as a reproductive genetic counselor at Brigham and Women’s Hospital’s Center for Fetal Medicine and Reproductive Genetics, supporting patients in genetic decision-making across the reproductive cycle from embryo screening to neonatal care.

“All medicine blends science and humanism, and genetics epitomizes this,” Llorin says. “The decision to undergo genetic testing is a personal one that intersects with ethics, family, and identity, and my role as a clinician is to help patients navigate this.”

She then worked as a genetic counselor at a telehealth clinic affiliated with 23andMe, where she trained physicians to integrate genetics into their primary care practice. Llorin developed tailored preventive care plans for patients with hereditary cancer and cardiac syndromes, elevated polygenic risk scores, and pharmacogenomics results.

At Atria, Llorin sees an opportunity to access the full potential of genomics for disease prediction and treatment selection. “In the traditional health care system, genetic information frequently is not sought, and when it is, it’s underutilized and siloed. Here, we’ve narrowed the gap between science and practice, so members benefit from the speed at which scientific knowledge of genetics is increasing,” Llorin says.

Llorin creates a patient-centered environment where families choose how and when they want to engage and access their genetic data. “Everyone has some degree of genetic susceptibility, but many have not gotten the right genetic testing, or have not yet worked with a care team that has integrated testing results into clinical care. At Atria, knowing these risks gives us an opportunity to intervene where it matters most and work towards precision health,” Llorin says.

A Brooklyn resident, Llorin enjoys running marathons, podcasts, and science nonfiction.